Hytera Wins Final Appeal Against Motorola Solutions at UK Supreme Court
SHENZHEN, China--(BUSINESS WIRE)--#CommunicationSolutions--On February 23, 2022, the Supreme Court of the United Kingdom dismissed an…
5 years ago
Chinachem Group joins hands with partners to support low-income groups with anti-epidemic supplies amid 5th COVID-19 wave
HONG KONG SAR - Media OutReach - 25 February 2022 - Chinachem Group (the Group)…
5 years ago
Oncocross Begins Clinical Trial for AI-Developed Drug for Sarcopenia
SEOUL, South Korea--(BUSINESS WIRE)--#AIBiotech--Oncocross, an AI-based drug development biotech, announced that it initiated a phase…
5 years ago
India Industrial Automation Market (2022 to 2027) – Growth, Trends, COVID-19 Impact, and Forecasts – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--India Industrial Automation Market (2022 to 2027) - Growth, Trends, COVID-19 Impact, and Forecasts…
5 years ago
Hungry Sausages Lab’s First NFT Collection Connects Digital Content to the Physical World as Uses Expand
HONG KONG SAR - Media OutReach - 25 February 2022 - Hungry Sausage Lab, a…
5 years ago
U.S. & Japan $796.5 Million Collagen Supplements Market to 2030: Increase in the Popularity of Gummies Likely to Foster Market Growth – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "U.S. & Japan Collagen Supplements Market by Source, Form and Sales Channel: Country…
5 years ago
Assessment of India’s Ready to Eat (RTE) Food Market, 2022-2026 – 18.63% CAGR Projected, Driven by the Growing Preference for Convenience Food Products and New Product Launches – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Ready to Eat Food Market in India 2022-2026" report has been added to…
5 years ago
BeiGene Reports Fourth Quarter and Full Year 2021 Financial Results
Recorded product revenue of $196.8 million and $634.0 million for the fourth quarter and full…
5 years ago
Spackman Media Group Artist Son Ye-Jin’s New K-Drama, 39, Breaks Its Own Highest Record In Audience Rating Since Its Premiere In Korea
Represented by MSteam, a wholly-owned subsidiary of Spackman Media Group, Son Ye-jin stars in JTBC’s…
5 years ago
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Approved in Japan for Radically Unresectable or Metastatic Renal Cell Carcinoma
Results From CLEAR/KEYNOTE-581 Showed KEYTRUDA Plus LENVIMA Significantly Reduced the Risk of Disease Progression or…
5 years ago